CN Patent
CN101479279B — 培南前药
Assigned to Pfizer Products Inc · Expires 2011-08-17 · 15y expired
What this patent protects
本发明涉及经口可生物利用的硫培南前药,例如式(I)化合物、其溶剂化物和水合物,所述硫培南前药的制备、制剂以及所述硫培南前药在治疗和预防诸如人类的哺乳动物中的感染的用途。
USPTO Abstract
本发明涉及经口可生物利用的硫培南前药,例如式(I)化合物、其溶剂化物和水合物,所述硫培南前药的制备、制剂以及所述硫培南前药在治疗和预防诸如人类的哺乳动物中的感染的用途。
Drugs covered by this patent
- Col-Probenecid (probenecid) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.